Moderna Vaccine Japan

Subject to regulatory approvals vaccine supply could begin during the first half of next year.

Moderna vaccine japan. By the end of september. Moderna has announced that the ministry of health labour and welfare of japan mhlw and takeda pharmaceutical agreed to purchase and distribute 50 million doses of its covid 19 vaccine candidate mrna 1273. Japan approved the arava rheumatoid arthritis drug in 2003 without conducting a late stage trial in the country. Pfizer and moderna have all entered phase three of clinical trials the final stage of testing before a vaccine can be approved.

Moderna is responsible for the manufacture and supply of moderna s vaccine candidate and takeda with the support of the mhlw the japan agency for medical research and development amed and moderna is responsible for all import local regulatory development and distribution activities in japan to ensure timely access starting during the first half of 2021. Japan will provide free covid 19 vaccines to all residents. Signed a contract with japan s government to supply 50 million doses of its covid 19 vaccine and said it is in advanced talks with the european union to expand vaccine supply there. Of moderna s vaccine from takeda pharmaceuticals co.

A japanese trial of u s based moderna s vaccine candidate is expected to begin soon. Japan s takeda pharmaceutical is responsible for handling the approval application here as well as sales and. Moderna confirmed in september that the swiss federal government had agreed to the procurement of 4 5 million vaccine doses of mrna 1273. Osaka japan october 29 2020 takeda pharmaceutical company limited tse 4502 nyse tak takeda today announced that it will import and distribute 50 million doses of moderna s covid 19 vaccine candidate mrna 1273 starting in the first half of 2021 pending licensure in japan.

This effort is part of a three way agreement among takeda moderna and the government of japan s.